According to the latest data from the Hong Kong Stock Exchange, on October 27, China Universal Fund Management Co., Ltd. reduced its holding in KEYMED BIO-B (02162) by 991,000 shares at a price of HK$70.8951 per share, for a total consideration of approximately HK$70.257 million.
Following the reduction, its latest shareholding stands at approximately 14.1975 million shares, representing a latest shareholding ratio of 4.75%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments